Zobrazeno 41 - 50
of 157
pro vyhledávání: '"Massimo Mapelli"'
Autor:
Fabiana De Martino, Irene Mattavelli, Carlo Vignati, Elisabetta Salvioni, Jeness Campodonico, Massimo Mapelli, Paola Gugliandolo, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Periodic breathing (PB) is a recognized sign of poor prognosis in heart failure (HF). It is defined as a cyclic fluctuation of minute ventilation, and oxygen uptake (V̇O2) and carbon dioxide elimination (V̇CO2) at the lungs. It is unknow whether PB
Autor:
Irene Mattavelli, Massimo Mapelli, Elisabetta Salvioni, Stefania Paolillo, Fabiana De Martino, Carlo Vignati, Damiano Magrì, Valentina Mantegazza, Gloria Tamborini, Teresa Capovilla, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background Sacubitril/Valsartan therapy has become a cornerstone of heart failure with reduced ejection fraction (HFrEF) pharmacological therapy due to its positive prognostic impact. However, conflicting results have emerged on the effects of sacubi
Autor:
Lucia Manfredini, Carlo Vignati, Elisabetta Salvioni, Irene Mattavelli, Massimo Mapelli, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Aims Erectile dysfunction (ED) is frequent in males with chronic heart failure (HF) with a severe impact on quality of life for many individuals. We evaluated the correlation between ED and HF severity, exercise capacity, treatment and psychological
Autor:
Matteo Palazzini, Laura Lupi, Enrico Ammirati, Cristina Giannattasio, Francesco Soriano, Patrizia Pedrotti, Daniele Briguglia, Massimo Mapelli, Jeness Campodonico, Piergiuseppe Agostoni, Sergio Leonardi, Annalisa Turco, Stefania Guida, Giovanni Peretto, Simone Sala, Paolo G Camici, Francesca Marzo, Aurelia Grosu, Michele Senni, Fabrizio Turrini, Manuela Bramerio, Marco Marini, Maria Vittoria Matassini, Stefania Rizzo, Cristina Basso, Monica De Gaspari, Nicholas S Hendren, Matthieu Schmidt, Thomas Bochaton, Nicolas Piriou, Aitor Ubarri, Caroline Van De Heyning, Albert Ariza Sole, Antonio Cannatà, Jorge Salamanca, Jukka Lehtonen, Florent Huang, Eric D Adler, Marco Metra
Publikováno v:
European Heart Journal Supplements. 24
Background Acute myocarditis (AM) is thought to be a rare cardiovascular complication of COVID-19, although minimal data are available beyond case reports. We aim to report the prevalence, baseline characteristics, in-hospital management, and outcome
Autor:
Massimo Mapelli, Maria Teresa Capovilla, Alessandro Marongiu, Gaspare Maranzano, Elisabetta Salvioni, Irene Mattavelli, Carlo Vignati, Paola Gugliandolo, Valentina Mantegazza, Anna Garlasché, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background Sodium-glucose co-transporter-2 inhibitors (SGLT2-i) are currently a standard therapy for patients with heart failure with reduced ejection fraction (HFrEF). Still, their potential benefits on biomarkers, respiratory function parameters an
Autor:
Elisabetta Salvioni, Massimo Mapelli, Alice Bonomi, Irene Mattavelli, Fabiana De Martino, Carlo Vignati, Paola Gugliandolo, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background In clinical practice, anaerobic threshold (AT), is used to guide training and rehabilitation programs, to define risk of major thoracic or abdominal surgery, and to assess prognosis in heart failure (HF). VO2AT has been reported as absolut
Autor:
Elisabetta Salvioni, Federica Moscucci, Alice Bonomi, Massimo Mapelli, Stefania Paolillo, Ugo Corrà, Carlo Vignati, Damiano Magrì, Susanna Sciomer, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background Heart failure (HF) in women often assumes extremely peculiar characteristics. The risk stratification and prognostic evaluation of HF in women is a challenge for clinicians. The actual prognostic scores are, in fact, lacking a specific sex
Autor:
Giulia Maiolo, Massimo Mapelli, Fabrizio Celeste, Edoardo Conte, Pietro Palermo, Elisabetta Mancini, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
A 71-year-old woman, known to have a non-ischemic dilated cardiomyopathy with reduced ejection fraction (EF), and a previous transcatheter edge-to-edge mitral valve repair (MitraClip), was admitted after a routine echocardiogram showing new onset mul
Autor:
Matteo Brusamolino, Nicola Amelotti, Massimo Mapelli, Andrea Baggiano, Jeness Campodonico, Benedetta Majocchi, Valentina Ribatti, Giulia Vettor, Giovanni Teruzzi, Daniela Trabattoni, Valeria Novelli, Valentina Catto, Cristina Basso, Gianluca Pontone, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background Acute myocarditis (AM) is a heart inflammatory disease that may also rarely occur as a complication of COVID-19 vaccines. Inflammation is involved in arrhythmogenic cardiomyopathy (ACM) pathogenesis. Little is known regarding the COVID-19
Autor:
Elisabetta Salvioni, Stfania Paolillo, Arianna Galotta, Massimo Mapelli, Irene Mattavelli, Christian Basile, Carlo Vignati, Federica Moscucci, Massimo Piepoli, Piergiuseppe Agostoni
Publikováno v:
European Heart Journal Supplements. 24
Background β-blockers are one of the four recommended disease-modifying classes of drugs for the treatment of heart failure with reduced ejection fraction (HFrEF). Although their efficacy and prognostic role is unquestionable in the general populati